Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
YD BioYDES +7.08%12 Days Inventory is 0.00 as of Dec. 2025. GuruFocus rates YDES with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 638 Biotechnology companies, YD Bio ranks worse than 88.4% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). YD Bio's Average Total Inventories for the
six
months ended in Dec. 2025 was $1.13 Mil. YD Bio's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $0.00 Mil.
The historical rank and industry rank for YD Bio's Days Inventory or its related term are showing as below:
YDES'
s Days Inventory Range Over the Past 10 Years
Min: 38.04 Med: 425.83 Max: 813.61
Current: 813.61
During the past 3 years, YD Bio's highest Days Inventory was 813.61. The lowest was 38.04. And the median was 425.83.
YDES's Days Inventory is ranked worse than 88.4% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs YDES: 813.61
YD Bio's Days Inventory
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
YD Bio's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
YD Bio's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.89.
YD Bio (NAS:YDES) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
YD Bio's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
YD Bio's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
YD Bio Days Inventory Related Terms
YD Bio Days Inventory Historical Data
* Premium members only.
The historical data trend for YD Bio's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YD Bio Days Inventory Chart
YD Bio Annual Data
Trend
Dec23
Dec24
Dec25
Days Inventory
0.00
38.04
813.61
YD Bio Semi-Annual Data
Dec24
Jun25
Dec25
Days Inventory
0.00
0.00
0.00
YDES vs CRBU, ABOS, PRQR: Days Inventory Comparison
For the Biotechnology subindustry, YD Bio's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YD Bio Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, YD Bio's Days Inventory distribution charts can be found below:
* The bar in red indicates where YD Bio's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YD Bio (YDES) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on YD Bio and its competitors. Over the past decade, YD Bio's Days Inventory has ranged from 38.04 to 813.61. According to the industry distribution chart, YD Bio ranks #564 out of 638 companies in the Biotechnology industry, placing it in the top 88.4%.
Is YD Bio's Days Inventory too high?
YD Bio's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 38.04 to a high of 813.61. Based on the distribution chart, YD Bio ranks #564 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, YD Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does YD Bio's Days Inventory compare to CRBU and ABOS?
According to the Biotechnology industry distribution chart, YD Bio ranks #564 out of 638 companies for Days Inventory. This places YD Bio in the lower half of its industry. The industry median Days Inventory is 183.20. Historically, YD Bio's own Days Inventory has ranged from 38.04 to 813.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on YD Bio and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. YD Bio's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YD Bio stock overvalued right now?
YD Bio (YDES) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. YD Bio's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For YD Bio (YDES), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
12GF Score
Get the complete analysis for YDES
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YDES has been successfully added to your 
